Correlation Between ChemoCentryx and Edesa Biotech

Can any of the company-specific risk be diversified away by investing in both ChemoCentryx and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChemoCentryx and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ChemoCentryx and Edesa Biotech, you can compare the effects of market volatilities on ChemoCentryx and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChemoCentryx with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChemoCentryx and Edesa Biotech.

Diversification Opportunities for ChemoCentryx and Edesa Biotech

0.0

Correlation Coefficient

ChemoCentryx  Edesa Biotech

Pay attention - limited upside

The 3 months correlation between ChemoCentryx and Edesa is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ChemoCentryx and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and ChemoCentryx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChemoCentryx are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of ChemoCentryx i.e., ChemoCentryx and Edesa Biotech go up and down completely randomly.

Pair Corralation between ChemoCentryx and Edesa Biotech

If you would invest  431.00  in Edesa Biotech on January 18, 2024 and sell it today you would earn a total of  9.00  from holding Edesa Biotech or generate 2.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

ChemoCentryx  vs.  Edesa Biotech

ChemoCentryx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ChemoCentryx has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, ChemoCentryx is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Edesa Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Edesa Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Edesa Biotech may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Pair Trading with ChemoCentryx and Edesa Biotech

The main advantage of trading using opposite ChemoCentryx and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChemoCentryx position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.

The idea behind ChemoCentryx and Edesa Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.